GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nuo Therapeutics, Inc. (AURX) | 8/17/2026 7:58:46 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $1,768,986 +152.6% | Assets $2,626,290 | Export Earnings Model | ||
| Nuo Therapeutics, Inc. (AURX) | 8/14/2026 5:22:21 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $1,768,986 +152.6% | Assets $2,626,290 | ||
| Nuo Therapeutics, Inc. (AURX) | 5/14/2026 5:14:27 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $1,302,115 +168.8% | Assets $1,945,669 | ||
| Nuo Therapeutics, Inc. (AURX) | 5/14/2026 5:12:24 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $1,302,115 +168.8% | Assets $1,945,669 | Export Earnings Model | ||
| Nuo Therapeutics, Inc. (AURX) | 3/30/2026 5:56:36 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $3,313,509 +142.7% | Assets $1,845,662 | ||
| Nuo Therapeutics, Inc. (AURX) | 10/30/2025 4:44:58 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $1,032,096 +178.2% | Assets $1,927,637 | ||
| Nuo Therapeutics, Inc. (AURX) | 10/30/2025 1:11:29 PM | View | Proxy | SEC | Y 2024 | ||||||
| Nuo Therapeutics, Inc. (AURX) | 7/31/2025 9:32:08 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $700,202 +92.0% | Assets $1,359,485 | ||
| Nuo Therapeutics, Inc. (AURX) | 4/30/2025 9:45:47 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $484,381 +106.5% | Assets $1,146,754 | ||
| Nuo Therapeutics, Inc. (AURX) | 4/1/2025 10:35:39 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $1,365,173 +124.3% | Assets $1,189,508 | ||
| Nuo Therapeutics, Inc. (AURX) | 11/12/2024 9:43:34 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $370,951 +59.7% | Assets $1,719,103 | ||
| Nuo Therapeutics, Inc. (AURX) | 8/12/2024 8:49:46 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $364,773 +208.7% | Assets $1,420,472 | ||
| Nuo Therapeutics, Inc. (AURX) | 5/15/2024 5:19:09 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $234,577 +283.9% | Assets $1,242,833 | ||
| Nuo Therapeutics, Inc. (AURX) | 4/19/2024 5:36:02 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $608,525 +442.1% | Assets $1,877,880 | ||
| Nuo Therapeutics, Inc. (AURX) | 11/20/2023 4:46:29 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $232,241 +507.2% | Assets $1,599,902 | ||
| Nuo Therapeutics, Inc. (AURX) | 8/14/2023 4:45:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $118,169 | Assets $1,385,279 | ||
| Nuo Therapeutics, Inc. (AURX) | 5/15/2023 5:10:52 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $61,100 | Assets $2,220,795 | ||
| Nuo Therapeutics, Inc. (AURX) | 4/18/2023 6:23:29 AM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Rev: $112,250 | Assets $3,047,360 | ||
| Nuo Therapeutics, Inc. (AURX) | 4/17/2023 6:22:02 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $112,250 | Assets $3,047,360 | ||
| Nuo Therapeutics, Inc. (AURX) | 11/4/2022 5:35:20 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $38,250 | Assets $3,864,812 | ||
| Nuo Therapeutics, Inc. (AURX) | 11/4/2022 5:35:17 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $149,930 | |||
| Nuo Therapeutics, Inc. (AURX) | 10/20/2022 8:34:41 AM | View | Proxy | SEC | Y 2021 | ||||||
| Nuo Therapeutics, Inc. (AURX) | 8/10/2022 2:17:21 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2022 ending: 6/30/2022 | Assets $4,323,151 | |||
| Nuo Therapeutics, Inc. (AURX) | 8/8/2022 4:59:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $4,323,151 | |||
| Nuo Therapeutics, Inc. (AURX) | 5/16/2022 5:11:37 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $1,058,200 | |||
| Nuo Therapeutics, Inc. (AURX) | 4/27/2022 4:34:55 PM | View | Proxy | SEC | Y 2021 | ||||||
| Nuo Therapeutics, Inc. (AURX) | 4/15/2022 5:26:00 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $1,465,918 | EPS -$0.03 | ||
| Nuo Therapeutics, Inc. (AURX) | 1/31/2020 5:15:59 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $57,883 -77.8% | Assets $38,495 | ||
| Nuo Therapeutics, Inc. (AURX) | 8/19/2019 5:04:57 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $44,165 -68.1% | Assets $154,338 | EPS -$0.02 | |
| Nuo Therapeutics, Inc. (AURX) | 5/20/2019 5:18:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $39,229 -75.5% | Assets $461,400 | EPS -$0.03 | |
| Nuo Therapeutics, Inc. (AURX) | 4/16/2019 5:39:06 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $1,370,594 +90.1% | Assets $975,497 | EPS -$0.07 | |
| Nuo Therapeutics, Inc. (AURX) | 11/16/2018 5:26:24 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $260,280 +60.5% | Assets $759,839 | EPS -$0.03 | |
| Nuo Therapeutics, Inc. (AURX) | 8/28/2018 8:34:11 AM | View | Proxy | SEC | Y 2017 | ||||||
| Nuo Therapeutics, Inc. (AURX) | 8/13/2018 5:07:54 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $138,309 -26.7% | Assets $823,326 | EPS -$0.03 | |
| Nuo Therapeutics, Inc. (AURX) | 5/14/2018 5:04:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $159,943 -7.4% | Assets $972,749 | EPS -$0.03 | |
| Nuo Therapeutics, Inc. (AURX) | 4/16/2018 4:48:39 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $721,045 -67.3% | Assets $1,424,039 | EPS -$1.02 | |
| Nuo Therapeutics, Inc. (AURX) | 11/13/2017 5:22:24 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $162,196 -8.2% | Assets $10,213,777 | EPS -$0.09 | |
| Nuo Therapeutics, Inc. (AURX) | 8/14/2017 6:16:21 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $188,600 -58.9% | Assets $8,839,766 | EPS -$0.39 | |
| Nuo Therapeutics, Inc. (AURX) | 5/15/2017 4:56:54 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $172,743 -90.0% | Assets $12,421,307 | EPS -$0.17 | |
| Nuo Therapeutics, Inc. (AURX) | 4/28/2017 12:03:05 PM | View | Proxy | SEC | Y 2016 | ||||||
| Nuo Therapeutics, Inc. (AURX) | 3/29/2017 5:30:00 AM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $2,204,666 -80.8% | Assets $14,056,753 | EPS -$0.43 | |
| Nuo Therapeutics, Inc. (AURX) | 11/14/2016 11:26:39 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $176,773 -91.9% | Assets $16,749,000 | EPS -$0.19 | |
| Nuo Therapeutics, Inc. (AURX) | 10/24/2016 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $458,729 -84.2% | Assets $19,600,968 | EPS $0.04 | |
| Nuo Therapeutics, Inc. (AURX) | 10/24/2016 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $1,732,221 -64.2% | Assets $24,049,746 | EPS $0.15 | |
| Nuo Therapeutics, Inc. (AURX) | 10/24/2016 5:30:00 AM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $11,510,977 +48.3% | Assets $7,073,745 | EPS -$0.42 | |
| Nuo Therapeutics, Inc. (AURX) | 11/13/2015 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $2,169,204 +28.2% | Assets $19,151,928 | EPS -$0.11 | |
| Nuo Therapeutics, Inc. (AURX) | 11/12/2015 8:43:37 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $2,169,204 +28.2% | Assets $19,151,928 | EPS -$0.11 | Export Earnings Model | |
| Nuo Therapeutics, Inc. (AURX) | 8/13/2015 5:27:46 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $2,895,231 +24.5% | Assets $46,466,803 | EPS -$0.01 | |
| Nuo Therapeutics, Inc. (AURX) | 8/13/2015 5:19:48 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $2,895,231 +24.5% | Assets $46,466,803 | EPS -$0.01 | Export Earnings Model | |
| Nuo Therapeutics, Inc. (AURX) | 5/14/2015 5:13:55 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $4,837,127 +162.0% | Assets $52,739,293 | EPS $0.02 | |
| Nuo Therapeutics, Inc. (AURX) | 5/14/2015 6:00:51 AM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $4,837,127 +162.0% | Assets $52,739,293 | EPS $0.02 | Export Earnings Model | |
| Nuo Therapeutics, Inc. (AURX) | 3/31/2015 5:21:36 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $7,761,934 -32.9% | Assets $56,224,605 | EPS -$0.16 | |
| Nuo Therapeutics, Inc. (AURX) | 3/31/2015 5:12:42 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $1,897,874 -45.2% | Assets $56,224,605 | EPS $0.02 | Export Earnings Model | |
| Nuo Therapeutics, Inc (AURX) | 11/13/2014 5:22:06 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $1,692,027 -49.7% | Assets $60,257,863 | EPS -$0.04 | |
| CYTOMEDIX INC (AURX) | 9/30/2014 6:01:57 PM | View | Proxy | SEC | Y 2013 | ||||||
| CYTOMEDIX INC (AURX) | 8/14/2014 4:34:19 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $2,326,104 -4.0% | Assets $65,333,978 | EPS -$0.09 | |
| CYTOMEDIX INC (AURX) | 5/15/2014 4:18:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $1,845,929 -20.3% | Assets $50,240,397 | EPS -$0.05 | |
| CYTOMEDIX INC (AURX) | 5/2/2014 4:58:38 PM | View | Proxy | SEC | Y 2013 | ||||||
| CYTOMEDIX INC (AURX) | 3/31/2014 5:28:48 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $11,571,438 +9.5% | Assets $46,252,280 | EPS -$0.20 | |
| CYTOMEDIX INC (AURX) | 11/12/2013 4:39:44 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $3,366,219 +91.3% | Assets $46,890,194 | EPS -$0.05 | |
| CYTOMEDIX INC (AURX) | 11/12/2013 6:01:48 AM | View | Proxy | SEC | Y 2012 | ||||||
| CYTOMEDIX INC (AURX) | 8/8/2013 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $2,423,898 -34.2% | Assets $46,572,284 | EPS -$0.05 | |
| CYTOMEDIX INC (AURX) | 5/9/2013 4:19:32 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $2,317,301 -23.2% | Assets $50,775,769 | EPS -$0.05 | |
| CYTOMEDIX INC (AURX) | 4/26/2013 4:33:24 PM | View | Proxy | SEC | Y 2012 | ||||||
| CYTOMEDIX INC (AURX) | 3/18/2013 4:13:48 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $10,564,220 +45.8% | Assets $44,331,441 | EPS -$0.24 | |
| CYTOMEDIX INC (AURX) | 2/20/2013 8:22:30 AM | View | Financials | Earnings | SEC | Y 2012 | Rev $2,102,802 -28.8% | Assets $44,331,441 | EPS -$0.04 | Export Earnings Model | |
| CYTOMEDIX INC (AURX) | 11/14/2012 9:46:38 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $1,759,311 +14.8% | Assets $47,538,953 | EPS -$0.04 | |
| CYTOMEDIX INC (AURX) | 8/20/2012 5:06:48 PM | View | Proxy | SEC | Y 2011 | ||||||
| CYTOMEDIX INC (AURX) | 8/14/2012 5:24:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $3,685,353 +164.3% | Assets $50,395,332 | EPS -$0.09 | |
| CYTOMEDIX INC (AURX) | 7/9/2012 6:03:08 PM | View | Financials | Earnings | SEC | 2Q 2012 | Rev $3,685,353 +164.3% | Assets $50,395,332 | EPS -$0.09 | Export Earnings Model | |
| CYTOMEDIX INC (AURX) | 5/15/2012 5:06:18 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $3,016,754 +120.9% | Assets $49,349,692 | EPS -$0.07 | |
| CYTOMEDIX INC (AURX) | 4/16/2012 4:48:12 PM | View | Proxy | SEC | Y 2011 | ||||||
| CYTOMEDIX INC (AURX) | 3/29/2012 4:43:39 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $7,247,399 +85.3% | Assets $10,078,492 | EPS -$0.08 | |
| CYTOMEDIX INC (AURX) | 11/14/2011 4:21:11 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $1,532,378 +18.1% | Assets $9,046,689 | EPS -$0.04 | |
| CYTOMEDIX INC (AURX) | 8/22/2011 4:45:24 PM | View | Proxy | SEC | Y 2010 | ||||||
| CYTOMEDIX INC (AURX) | 8/15/2011 4:39:48 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $1,394,294 +21.5% | Assets $7,964,425 | EPS -$0.02 | |
| CYTOMEDIX INC (AURX) | 8/25/2010 4:14:38 PM | View | Proxy | SEC | Y 2009 | ||||||
| CYTOMEDIX INC (AURX) | 5/26/2010 8:31:59 PM | View | Proxy | SEC | Y 2009 | ||||||
| CYTOMEDIX INC (AURX) | 8/11/2009 1:42:49 PM | View | Proxy | SEC | Y 2008 |